Literature DB >> 28109741

Eight unexpected cases of vancomycin associated acute kidney injury with contemporary dosing.

J Nicholas O'Donnell1, Cybele Ghossein2, Nathaniel J Rhodes1, Jessica Peng3, Tina Lertharakul3, C Kim Pham3, Marc H Scheetz4.   

Abstract

Vancomycin is one of the most commonly utilized antibiotics in US hospitals. It remains the drug of choice for the treatment of serious infections caused by methicillin-resistant Staphylococcus aureus. For many of these deep-seated infections, guidelines recommend achieving troughs of 15-20 mg/L for treatment efficacy. At our institution we observed a number of cases of presumed vancomycin-induced acute tubular necrosis clinically diagnosed by the nephrology service. We report eight cases of presumed vancomycin-induced acute tubular necrosis, three of which required hemodialysis before resolution of nephrotoxicity. Only three of the eight patients received nephrotoxins prior to development of nephrotoxicity. All eight patients ultimately recovered renal function following discontinuation.
Copyright © 2016 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute tubular necrosis; Hemodialysis; Kidney injury; Vancomycin

Mesh:

Substances:

Year:  2017        PMID: 28109741      PMCID: PMC5386811          DOI: 10.1016/j.jiac.2016.12.011

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  35 in total

1.  In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.

Authors:  Faruk Oktem; Meltem Koyuncu Arslan; Fehmi Ozguner; Ozden Candir; H Ramazan Yilmaz; Metin Ciris; Efkan Uz
Journal:  Toxicology       Date:  2005-08-19       Impact factor: 4.221

2.  Impact of vancomycin treatment duration and dose on kidney injury.

Authors:  Kirsten Bosch; Milena M McLaughlin; John S Esterly; Nathaniel J Rhodes; Michael J Postelnick; Marc H Scheetz
Journal:  Int J Antimicrob Agents       Date:  2013-12-07       Impact factor: 5.283

3.  Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael J Rybak; Ben M Lomaestro; John C Rotschafer; Robert C Moellering; Willam A Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079

4.  Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime.

Authors:  Diane M Gomes; Carmen Smotherman; Amy Birch; Lori Dupree; Bethany J Della Vecchia; Dale F Kraemer; Christopher A Jankowski
Journal:  Pharmacotherapy       Date:  2014-04-18       Impact factor: 4.705

5.  Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.

Authors:  Richard G Wunderink; Michael S Niederman; Marin H Kollef; Andrew F Shorr; Mark J Kunkel; Alice Baruch; William T McGee; Arlene Reisman; Jean Chastre
Journal:  Clin Infect Dis       Date:  2012-01-12       Impact factor: 9.079

6.  Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort.

Authors:  Ravina Kullar; Susan L Davis; Thomas N Taylor; Keith S Kaye; Michael J Rybak
Journal:  Pharmacotherapy       Date:  2012-03       Impact factor: 4.705

7.  Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans.

Authors:  Kavitha K Prabaker; Thuong P-H Tran; Tamara Pratummas; Matthew Bidwell Goetz; Christopher J Graber
Journal:  J Hosp Med       Date:  2011-11-15       Impact factor: 2.960

8.  Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.

Authors:  Vishal S Vaidya; Josef S Ozer; Frank Dieterle; Fitz B Collings; Victoria Ramirez; Sean Troth; Nagaraja Muniappa; Douglas Thudium; David Gerhold; Daniel J Holder; Norma A Bobadilla; Estelle Marrer; Elias Perentes; André Cordier; Jacky Vonderscher; Gérard Maurer; Peter L Goering; Frank D Sistare; Joseph V Bonventre
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

Review 9.  Biopsy proven acute tubular necrosis associated with vancomycin in a child: case report and literature review.

Authors:  Chan-Yao Wu; Jyh-Seng Wang; Yee-Hsuan Chiou; Chen-Yin Chen; Yu-Tsun Su
Journal:  Ren Fail       Date:  2007       Impact factor: 2.606

10.  Indications and Types of Antibiotic Agents Used in 6 Acute Care Hospitals, 2009-2010: A Pragmatic Retrospective Observational Study.

Authors:  Theodoros Kelesidis; Nikolay Braykov; Daniel Z Uslan; Daniel J Morgan; Sumanth Gandra; Birgir Johannsson; Marin L Schweizer; Scott A Weisenberg; Heather Young; Joseph Cantey; Eli Perencevich; Edward Septimus; Arjun Srinivasan; Ramanan Laxminarayan
Journal:  Infect Control Hosp Epidemiol       Date:  2015-10-12       Impact factor: 3.254

View more
  2 in total

1.  24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury.

Authors:  J Nicholas O'Donnell; Nathaniel J Rhodes; Thomas P Lodise; Walter C Prozialeck; Cristina M Miglis; Medha D Joshi; Natarajan Venkatesan; Gwendolyn Pais; Cameron Cluff; Peter C Lamar; Seema Briyal; John Z Day; Anil Gulati; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

2.  Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study.

Authors:  Ahmed A Mahmoud; Sean N Avedissian; Abbas Al-Qamari; Tiffany Bohling; Michelle Pham; Marc H Scheetz
Journal:  Clin Pharmacokinet       Date:  2020-12       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.